Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Mateos

Showing results (111-120 of 175) with videos related to

Pageof 18
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 16, 1998
Prognostic value of immunophenotypic detection of minimal residual disease in acute lymphoblastic leukemiaJ Ciudad, J F San Miguel, M C López-Berges, et al.
Haematologica|April 6, 1999
Heteroduplex PCR analysis of rearranged immunoglobulin genes for clonality assessment in multiple myelomaR García-Sanz, R López-Pérez, A W Langerak, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|March 29, 2002
p16/INK4a gene inactivation by hypermethylation is associated with aggressive variants of monoclonal gammopathiesM V Mateos, R Garcia-Sanz, R López-Pérez, et al.
Bone Marrow Transplantation|November 13, 2001
Gene scanning of VDJH-amplified segments is a clinically relevant technique to detect contaminating tumor cells in the apheresis products of multiple myeloma patients undergoing autologous peripheral blood stem cell transplantationR López-Pérez, R García-Sanz, D González, et al.
Bone Marrow Transplantation|November 22, 2016
Absence of spontaneous response improvement beyond day +100 after autologous stem cell transplantation in multiple myelomaC Fernández de Larrea, J Dávila, I Isola, et al.
Bone Marrow Transplantation|January 11, 2000
Clinical significance of CD34+ cell dose in long-term engraftment following autologous peripheral blood stem cell transplantationJ A Pérez-Simón, A Martín, D Caballero, et al.
Leukemia|August 15, 2000
The detection of contaminating clonal cells in apheresis products is related to response and outcome in multiple myeloma undergoing autologous peripheral blood stem cell transplantationR López-Pérez, R García-Sanz, D González, et al.
Clinical Hematology International|October 1, 2021
Plasma Cell Leukemia - Facts and Controversies: More Questions than Answers?Anna Suska, David H Vesole, Jorge J Castillo, et al.
Genes, Chromosomes & Cancer|November 24, 1999
Two new 3' PML breakpoints in t(15;17)(q22;q21)-positive acute promyelocytic leukemiaM C Chillón, M González, R García-Sanz, et al.
Leukemia|April 26, 2017
Efficacy and safety of carfilzomib regimens in multiple myeloma patients relapsing after autologous stem cell transplant: ASPIRE and ENDEAVOR outcomesP Hari, M-V Mateos, R Abonour, et al.
Pageof 18

Showing results (111-120 of 175) with videos related to

Sort By:
Pageof 18
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 16, 1998
Prognostic value of immunophenotypic detection of minimal residual disease in acute lymphoblastic leukemiaJ Ciudad, J F San Miguel, M C López-Berges, et al.
Haematologica|April 6, 1999
Heteroduplex PCR analysis of rearranged immunoglobulin genes for clonality assessment in multiple myelomaR García-Sanz, R López-Pérez, A W Langerak, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|March 29, 2002
p16/INK4a gene inactivation by hypermethylation is associated with aggressive variants of monoclonal gammopathiesM V Mateos, R Garcia-Sanz, R López-Pérez, et al.
Bone Marrow Transplantation|November 13, 2001
Gene scanning of VDJH-amplified segments is a clinically relevant technique to detect contaminating tumor cells in the apheresis products of multiple myeloma patients undergoing autologous peripheral blood stem cell transplantationR López-Pérez, R García-Sanz, D González, et al.
Bone Marrow Transplantation|November 22, 2016
Absence of spontaneous response improvement beyond day +100 after autologous stem cell transplantation in multiple myelomaC Fernández de Larrea, J Dávila, I Isola, et al.
Bone Marrow Transplantation|January 11, 2000
Clinical significance of CD34+ cell dose in long-term engraftment following autologous peripheral blood stem cell transplantationJ A Pérez-Simón, A Martín, D Caballero, et al.
Leukemia|August 15, 2000
The detection of contaminating clonal cells in apheresis products is related to response and outcome in multiple myeloma undergoing autologous peripheral blood stem cell transplantationR López-Pérez, R García-Sanz, D González, et al.
Clinical Hematology International|October 1, 2021
Plasma Cell Leukemia - Facts and Controversies: More Questions than Answers?Anna Suska, David H Vesole, Jorge J Castillo, et al.
Genes, Chromosomes & Cancer|November 24, 1999
Two new 3' PML breakpoints in t(15;17)(q22;q21)-positive acute promyelocytic leukemiaM C Chillón, M González, R García-Sanz, et al.
Leukemia|April 26, 2017
Efficacy and safety of carfilzomib regimens in multiple myeloma patients relapsing after autologous stem cell transplant: ASPIRE and ENDEAVOR outcomesP Hari, M-V Mateos, R Abonour, et al.
Pageof 18